In this edition of the JDD Podcast, Ask the Investigator, host Dr. Adam Friedman from GW School of Medicine welcomes back dermatology rock star Dr. Darrell Rigel to discuss his most recent study published in the May 2017 edition of the Journal of Drugs in Dermatology entitled "Impact of a 31-gene Expression Profiling Test for Cutaneous Melanoma on Dermatologists’ Clinical Management Decisions." See education in action as Dr. Rigel and colleagues demonstrate changes in dermatology resident management strategies for melanoma with the addition of a genetic profiling assay to the standard tumor grading tools. Can a fancy shmancy molecular marvel improve how we manage our patients and collaborate with other specialties? Can the 31-gene expression profiling test grant me three wishes? Tune in find out.